NewsBenzingaNeuroPace senkt den Umsatz-Ausblick für das Geschäftsjahr 2026 von 99,500 Mio. $–101,500 Mio. $ auf 91,000 Mio. $–92,000 Mio. $ gegenüber der Schätzung von 100,321 Mio. $ NeuroPace senkt den Umsatz-Ausblick für das Geschäftsjahr 2026 von 99,500 Mio. $–101,500 Mio. $ auf 91,000 Mio. $–92,000 Mio. $ gegenüber der Schätzung von 100,321 Mio. $ Benzinga 2026.11.12 21:11 (GMT+0) Open on Benzinga Other news Is Wall Street Bullish or Bearish on Zimmer Biomet Stock? Clorox Stock Outlook: Is Wall Street Bullish or Bearish? Shorting ConocoPhillips Puts and Put Credit Spreads Are Attractive Income Plays Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report How To Earn $500 A Month From Target Stock Ahead Of Q3 Earnings Stifel Reinstates Buy on Walmart, Announces $145 Price Target
Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report